Connection
Claudia Clavijo to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Claudia Clavijo has written about Dose-Response Relationship, Drug.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.051 |
|
|
|
-
Elkomy MH, Sultan P, Carvalho B, Peltz G, Wu M, Clavijo C, Galinkin JL, Drover DR. Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndrome. Clin Pharmacol Ther. 2015 Feb; 97(2):167-76.
Score: 0.020
-
Atkinson Ralls L, Drover DR, Clavijo CF, Carvalho B. Prior epidural lidocaine alters the pharmacokinetics and drug effects of extended-release epidural morphine (DepoDurĀ®) after cesarean delivery. Anesth Analg. 2011 Aug; 113(2):251-8.
Score: 0.016
-
Steudel W, Dingmann C, Zhang YL, Bendrick-Peart J, Clavijo C, Shulze J, Betts R, Christians U. Randomized, double-blind, placebo-controlled, single intravenous dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of the novel coronary smooth muscle cell proliferation inhibitor Biolimus A9 in healthy individuals. J Clin Pharmacol. 2011 Jan; 51(1):29-39.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|